Elevance Health Stock - Analyst estimates and sector context at week’s end

Elevance Health stock ends the week with solid fundamentals and close analyst attention. Here is how Wall Street’s earnings estimates stack up against peers in the managed care sector and where the Standard & Poor’s 500 index constituent currently trades.

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 19:35 UTC. Details in the imprint.

Elevance Health (US2855211023) sits among the largest US managed care groups. With no fresh market-moving headlines today, the stock is mainly viewed through its current analyst estimates and its position in the health insurance peer group this week.

How analysts currently view Elevance

Wall Street coverage on Elevance Health remains broad, with several dozen banks and research houses publishing estimates for the Standard & Poor’s 500 index constituent. Consensus points to continued revenue growth and stable margins in the core insurance business.

Across the sector, analysts frequently highlight Elevance Health’s scale advantages and the growing contribution from its Carelon health services arm. That division is seen as a way to balance medical cost trends in traditional health plans while keeping earnings less volatile than smaller peers.

Weekly positioning versus peers

Into the end of the week, Elevance Health shares trade in a market that has lately reassessed managed care valuations after swings in medical cost expectations. The stock is often discussed alongside UnitedHealth Group, CVS Health and Cigna in sector reviews.

According to recent sector commentary, Elevance Health’s valuation metrics, such as forward earnings multiples, sit at a moderate discount to some larger peers, reflecting both regulatory uncertainty and its diversified but still insurer-heavy profile. This discount is watched closely by value-oriented investors.

How the company makes money

Elevance Health generates most of its revenue from health insurance plans across commercial, Medicaid and Medicare lines, complemented by specialty benefits like pharmacy and dental coverage. The Carelon platform adds fee-based services such as behavioral health, care management and data-driven clinical solutions.

Where the stock trades today

The shares of Elevance Health (US2855211023) trade on the New York Stock Exchange at $388.77 as of 06/18/2026, 15:59 Eastern Time.

Key facts on Elevance Health stock

• Company: Elevance Health, Inc.
• ISIN: US2855211023
• WKN: A3DJBL
• Ticker: ELV
• Venue: NYSE
• Price (as of 06/18/2026, 15:59 Eastern Time): 388.77 USD
• Market cap: 90,000,000,000 USD (as of 06/18/2026, based on latest available quote and share count)
• Sector / Industry: Health Care - Managed Health Care
• Index membership: Standard & Poor’s 500 index
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.